Bimatoprost is the active ingredient in Latisse, so they are not different drugs. Latisse is simply the brand name for a specific formulation of bimatoprost 0.03% that the FDA approved in December 2008 for growing longer, thicker, darker eyelashes. If you’ve seen bimatoprost mentioned elsewhere, it’s the same compound, but the context and packaging matter more than you might expect.
What Latisse Actually Contains
Latisse is a 0.03% bimatoprost ophthalmic solution, meaning each milliliter contains 0.3 mg of bimatoprost. It’s classified as a synthetic prostaglandin analog, a compound that mimics naturally occurring signaling molecules in the body. The remaining ingredients are standard pharmaceutical fillers: benzalkonium chloride (a preservative), sodium chloride, sodium phosphate, and citric acid.
If you’ve come across “generic bimatoprost 0.03%” sold for eyelash growth, it contains the same active ingredient at the same concentration. The difference is branding, price, and whether it comes with FDA-approved sterile applicators designed for lash-line use.
Bimatoprost for Eyes vs. Bimatoprost for Lashes
Here’s where things get interesting. Bimatoprost 0.03% is also sold under the brand name Lumigan, a prescription eye drop for glaucoma. Lumigan and Latisse share the same active ingredient, the same concentration, and similar inactive ingredients. But they are packaged and applied very differently.
Lumigan is dispensed as an eye drop directly into the eye to lower pressure inside the eyeball. Latisse is applied only to the skin of the upper eyelid margin using a thin, disposable applicator brush. When applied this way, the volume of bimatoprost reaching tissue is roughly 5% of what an eye drop delivers. You’re not supposed to put Latisse directly into your eye or apply it to your lower lash line.
This distinction matters because doctors noticed that glaucoma patients using Lumigan were growing remarkably long eyelashes as a side effect. That observation led the manufacturer, Allergan, to seek a separate FDA approval specifically for eyelash growth, and Latisse was born. Same molecule, different purpose, different delivery method.
How Bimatoprost Grows Lashes
Every eyelash goes through a growth cycle with three phases: an active growth phase (anagen), a transition phase, and a resting phase before the lash falls out. At any given time, your lashes are in different stages of this cycle, which is why they don’t all fall out at once.
Bimatoprost works by extending the anagen phase, keeping lashes in active growth for longer than they normally would be. Prostaglandin receptors sit in two key structures of the hair follicle: the dermal papilla (the base that feeds the hair) and the outer root sheath. When bimatoprost binds to these receptors, it signals the follicle to keep producing hair. The result is lashes that grow longer before entering their resting phase, and the follicle also tends to produce thicker, more pigmented hairs.
How Long Results Take
Bimatoprost is not fast-acting. You’re essentially resetting the growth cycle of your lash follicles, which takes time. Most people notice the first subtle changes around weeks four to five, often starting with slightly longer lashes at the outer corners of the eyes. Visible improvements in length, thickness, and darkness typically become clear between weeks eight and twelve. The best results generally appear with consistent daily use around weeks twelve to sixteen.
If you stop applying bimatoprost, your lashes gradually return to their original appearance over several weeks to months as the growth cycle resets to its natural length.
Side Effects to Know About
Because Latisse and generic bimatoprost are the same drug, they carry the same side effects. The most commonly reported ones are mild: redness or itching where the solution contacts skin, and a feeling of dryness in the eyes.
Two side effects deserve special attention. First, bimatoprost can darken the skin of your eyelids. This typically reverses within weeks to months after you stop using the product. Second, and more notably, bimatoprost can permanently darken the colored part of your eye (the iris). This is most relevant for people with hazel, green, or mixed-color irises, where the change would be noticeable. For people with already dark brown eyes, this effect is less visible. The eyelid darkening is reversible, but the iris color change may not be.
These risks are identical whether you use brand-name Latisse, generic bimatoprost, or even repurpose Lumigan eye drops on your lashes (something some people do off-label to save money, though without the proper applicators).
Brand Name vs. Generic: What You’re Paying For
Latisse typically costs significantly more than generic bimatoprost 0.03%, and the main practical difference is the packaging. Latisse comes with single-use sterile applicator brushes specifically designed for the upper lash line. Generic versions may or may not include applicators, meaning you’d need to buy fine-tipped brushes separately.
The FDA approval for Latisse also means it has undergone specific clinical trials demonstrating its safety and effectiveness for eyelash growth. Generic bimatoprost contains the same drug but may be marketed for glaucoma rather than cosmetic use, which affects how your doctor prescribes it and whether insurance covers it. For eyelash growth specifically, insurance rarely covers either version since it’s considered cosmetic.
Both require a prescription in the United States. If you encounter bimatoprost sold without a prescription online, that’s a separate concern about product legitimacy and regulatory compliance rather than a difference in the drug itself.